Literature DB >> 20658089

Correlation between quality of life and functional capacity in cardiac failure.

Ivan Daniel Bezerra Nogueira1, Denise Maria Servantes, Patrícia Angélica de Miranda Silva Nogueira, Amália Pelcerman, Xiomara Miranda Salvetti, Fernando Salles, Dirceu Rodrigues Almeida, Marco Túlio de Mello, Orlando Campos Filho, Japy Angelini Oliveira Filho.   

Abstract

BACKGROUND: Patients with cardiac failure (CF) present progressive incapacity and decreased quality of life, both related to dyspnea and fatigue. Thus, there is the increasing interest in measuring the quality of life (QL), by generic instrument, such as the 36-item Short-Form Health Survey (SF-36), by specific instrument, such as Minnesota Living with Heart Failure (MLHFQ).
OBJECTIVE: This study has the objective to correlate the QL surveys, SF-36 and MLHFQ, with the functional capacity of patients with CF, expressed by the cardiopulmonary test and the TC6M.
METHODS: Using the SF-36 and MLHFQ surveys for QL evaluation, for the evaluation of the functional capacity, it was used the cardiopulmonary test, being executed using a tredmill with Weber protocol, as well sa the distance covered in the walk test of six minutes (TC6M).
RESULTS: Forty-six patients were selected with CF diagnosis (22 men, average age of 52 years old), classes II and III of New York Heart Association. It was observed that the mild correlation between the physical and emotional domains of SF-36 and VE/VCO2.peak (r=-0.3; p<0.05) and the distance covered in TC6M (r=0.4; p<0.05), respectively. It was also observed the mild to moderate correlations of MLHFQ total score with VO2.peak (r=-0.5; p<0.05), the aerobic threshold (r=-0.4; p<0.05) and the distance covered in TC6M (r=-0.5; p<0.05).
CONCLUSION: The data suggest that the application of both evaluation instruments of QL, generic (SF-36) and specific (MLHFQ) in patients with CF, showed mild and moderate correlation with the variable of the cardiopulmonary test with the variables of the cardiopulmonary test and the distance covered in TC6M.

Entities:  

Mesh:

Year:  2010        PMID: 20658089     DOI: 10.1590/s0066-782x2010005000096

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension.

Authors:  Yi-Jen Chen; Hung-Pin Tu; Chia-Ling Lee; Wei-Chun Huang; Jin-Shiou Yang; Cyuan-Fong Li; Chia-Hsin Chen; Ko-Long Lin
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

2.  Clinical characteristics of heart failure associated with functional dependence at admission in hospitalized elderly.

Authors:  Sara de Oliveira Xavier; Renata Eloah de Lucena Ferretti-Rebustini
Journal:  Rev Lat Am Enfermagem       Date:  2019-04-29

3.  Haemodynamic determinants of quality of life in chronic heart failure.

Authors:  Serlie Fatrin; Nduka C Okwose; Kristian Bailey; Lazar Velicki; Dejana Popovic; Arsen Ristic; Petar M Seferovic; Guy A MacGowan; Djordje G Jakovljevic
Journal:  BMC Cardiovasc Disord       Date:  2022-09-16       Impact factor: 2.174

4.  Assessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life.

Authors:  Henrique Silveira Costa; Rafael Leite Alves; Stela Alves da Silva; Maria Clara Noman Alencar; Maria do Carmo Pereira Nunes; Márcia Maria Oliveria Lima; Manoel Otávio da Costa Rocha
Journal:  Int J Prev Med       Date:  2014-02

5.  Depression after CABG: a prospective study.

Authors:  Joana Kátya Veras Rodrigues Sampaio Nunes; José Albuquerque de Figueiredo Neto; Rosângela Maria Lopes de Sousa; Vera Lívia Xavier de Castro Costa; Flor de Maria Araújo Mendonça Silva; Ana Flávia Lima Teles da Hora; Edna Lúcia Coutinho da Silva; Lívia Mariane Castelo Branco Reis
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec

6.  Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.

Authors:  Stefan D Anker; Piotr Ponikowski; Muhammad Shahzeb Khan; Tim Friede; Ewa A Jankowska; Vincent Fabien; Udo-Michael Goehring; Marco Metra; Ileana L Piña; Andrew J S Coats; Giuseppe Rosano; Fabio Dorigotti; Josep Comin-Colet; Dirk J Van Veldhuisen; Gerasimos S Filippatos; Javed Butler
Journal:  Eur J Heart Fail       Date:  2022-04-21       Impact factor: 17.349

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.